Cargando…
Virus-Vectored Influenza Virus Vaccines
Despite the availability of an inactivated vaccine that has been licensed for >50 years, the influenza virus continues to cause morbidity and mortality worldwide. Constant evolution of circulating influenza virus strains and the emergence of new strains diminishes the effectiveness of annual vacc...
Autores principales: | Tripp, Ralph A., Tompkins, S. Mark |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4147686/ https://www.ncbi.nlm.nih.gov/pubmed/25105278 http://dx.doi.org/10.3390/v6083055 |
Ejemplares similares
-
Identification of Virulence Determinants in Influenza
Viruses
por: Negri, Pierre, et al.
Publicado: (2014) -
Repurposing Probenecid to Inhibit SARS-CoV-2, Influenza Virus, and Respiratory Syncytial Virus (RSV) Replication
por: Tripp, Ralph A., et al.
Publicado: (2022) -
Bat cells from Pteropus alecto are susceptible to influenza A virus infection and reassortment
por: Dlugolenski, Daniel, et al.
Publicado: (2013) -
Innovation in Newcastle Disease Virus Vectored Avian Influenza Vaccines
por: Kim, Shin-Hee, et al.
Publicado: (2019) -
Induction and Role of Indoleamine 2,3 Dioxygenase in Mouse Models of Influenza A Virus Infection
por: Huang, Lei, et al.
Publicado: (2013)